Dr. Kundu obtained M.Tech and Ph.D. from the Indian Institute of Technology Kharagpur in Biotechnology, and molecular biology/biochemistry, respectively. He also pursued a year of fellowship at the National University of Singapore to study active transport across renal proximal cells. During his postdoctoral training (with Dr. Sunil Sudarshan, M.D.) at the University of Alabama at Birmingham, Dr. Kundu studied the molecular understanding of kidney cancer pathobiology in areas like metabolism, signal transduction, and transcription and translation regulation. He was awarded a research fellowship from the American Urological Association, a concept award, and an early career scholar award from the Department of Defense to study semaphorin biology in renal cell carcinoma.  

Cancer Focus

My laboratory aims to ask fundamental questions related to signal transduction, metabolism, epigenetics, and epitranscriptomics using kidney cancer as a model system. We focus on the signaling cues that regulate crosstalk among epigenetic/epitranscriptomic factors. Using this knowledge, we study the mechanisms of how tumor cells grow uncontrollably, escape immunity, and pose therapy resistance. In addition, I aim to build effective collaboration to study alternative in vitro tumor models alongside racial disparities in GU malignancies.